People

Meredith Redwine specializes in defending pharmaceutical and medical device manufacturers in product liability suits. A partner in our Product Liability practice, Meredith represents manufacturers in large-scale, multi-district and mass tort litigation as well as individual product liability actions.

Meredith has substantial experience in representing large pharmaceutical and medical device companies in a variety of product liability actions in state and federal courts across the country. Her experience includes trial and mediation; working with expert witnesses in the preparation of scientific causation opinions; preparing and defending expert witnesses and company witnesses; deposing plaintiffs and prescribing and treating physicians; coordinating discovery; and briefing dispositive and procedural motions.

In addition, Meredith has engaged in large-scale product liability settlement negotiations, evaluating thousands of cases and claims, and structuring and managing settlements.

Meredith was named by Law360 as one of only five Rising Stars for Product Liability Litigation in 2017 and a 2011 Georgia Rising Star by Super Lawyers.  Sheis a frequent speaker on issues relating to drug and medical device litigation.

Full Bio

Credentials

J.D., University of Georgia School of Law, summa cum laude, Order of the Coif

B.S., University of Georgia, summa cum laude with highest honors

Georgia

Supreme Court of Georgia

U.S. Court of Appeals for the Eleventh Circuit

U.S. Court of Appeals for the Fifth Circuit

U.S. Court of Appeals for the Second Circuit

U.S. District Court for the Northern District of Georgia

U.S. District Court for the Western District of Tennessee

Law Clerk, Thomas W. Thrash, Jr., U.S. District Court for the Northern District of Georgia

Defense Research Institute

Graduate, International Association of Defense Counsel’s Trial Academy, 2015

International Association of Defense Counsel

Order of Barristers, University of Georgia School of Law, 2004

Order of the Coif, University of Georgia School of Law, 2004

State Bar of Georgia

Rising Star: Product Liability Litigation


Law360, 2017

Georgia Rising Star: Product Liability Litigation


Super Lawyers, 2011

Outstanding Mock Trial Advocate


University Of Georgia School Of Law, 2004

Regional Champion and Best Brief Award


National Moot Court Competition, 2003

Icon close

Close

Recognition

Rising Star: Product Liability Litigation


Law360, 2017

Georgia Rising Star: Product Liability Litigation


Super Lawyers, 2011

Outstanding Mock Trial Advocate


University Of Georgia School Of Law, 2004

Regional Champion and Best Brief Award


National Moot Court Competition, 2003

Matters

Serves as core member of national coordinating and trial counsel team representing GlaxoSmithKline in nationwide product liability litigation concerning alleged associations between Paxil and birth defects, autism spectrum disorders, andsuicidality.  Ms. Redwine has experience conducting, coordinating, and managing discovery; drafting of dispositive and procedural motions; and trial preparation as well as working with expert witnesses that have spanned a broad array of scientific disciplines (teratology, obstetrics and maternal-fetal medicine, pediatric cardiology, developmental biology, genetics, and epidemiology).  Ms. Redwine currently manages the docket of cases, including conducting discovery and formulating litigation strategy, concerning allegations that maternal use of Paxil caused development of autism spectrum disorders in children exposed in utero.

Successfully represented GlaxoSmithKline in Rader v. GSK, a case involving allegations that Paxil caused a congenital heart defect (Tetralogy of Fallot). After two weeks of trial, the Philadelphia Court of Common Pleas granted a directed verdict for GSK for lack of evidence of learned intermediary proximate cause. Ms. Redwine also represented GlaxoSmithKline at two other  bellwether trials in the Philadelphia Court of Common Pleas involving allegations of birth defects caused by Paxil.

Successfully briefed and argued motion for summary judgment on various grounds, including statute of limitations, and assisted in obtaining dismissal on Daubert grounds for GlaxoSmithKline in a case alleging that maternal Paxil use caused congenital bicuspid aortic valve. (K.E. v. GlaxoSmithKline, 2017 WL 440242 (D. Conn. Feb. 1, 2017)).

See more
Icon close

Close

Matters

Serves as core member of national coordinating and trial counsel team representing GlaxoSmithKline in nationwide product liability litigation concerning alleged associations between Paxil and birth defects, autism spectrum disorders, andsuicidality.  Ms. Redwine has experience conducting, coordinating, and managing discovery; drafting of dispositive and procedural motions; and trial preparation as well as working with expert witnesses that have spanned a broad array of scientific disciplines (teratology, obstetrics and maternal-fetal medicine, pediatric cardiology, developmental biology, genetics, and epidemiology).  Ms. Redwine currently manages the docket of cases, including conducting discovery and formulating litigation strategy, concerning allegations that maternal use of Paxil caused development of autism spectrum disorders in children exposed in utero.

Successfully represented GlaxoSmithKline in Rader v. GSK, a case involving allegations that Paxil caused a congenital heart defect (Tetralogy of Fallot). After two weeks of trial, the Philadelphia Court of Common Pleas granted a directed verdict for GSK for lack of evidence of learned intermediary proximate cause. Ms. Redwine also represented GlaxoSmithKline at two other  bellwether trials in the Philadelphia Court of Common Pleas involving allegations of birth defects caused by Paxil.

Successfully briefed and argued motion for summary judgment on various grounds, including statute of limitations, and assisted in obtaining dismissal on Daubert grounds for GlaxoSmithKline in a case alleging that maternal Paxil use caused congenital bicuspid aortic valve. (K.E. v. GlaxoSmithKline, 2017 WL 440242 (D. Conn. Feb. 1, 2017)).

Obtained dismissal for GlaxoSmithKline of numerous claims, under Twombly/Iqbal, in a case alleging that Paxil caused adult valvular heart disease. Later, obtained summary judgment of remaining claims based on statute of limitations, and successfully briefed appeal to the United States Court of Appeals for the Fifth Circuit. (McLaughlin v. GSK, 2014 WL 669349 (W.D. La. Jan. 6, 2014) and 2014 WL 2200868 (W.D. La. May 27, 2014), aff'd 601 F. App'x 312 (5th Cir. Mar. 3, 2015)).

Obtained summary judgment for GlaxoSmithKline in a case alleging maternal Paxil use caused a congenital limb defect after the Court excluded plaintiffs' general and specific causation expert witnesses. (Frischhertz v. GSK, 2012 WL 6697124 (E.D. La. Dec. 21, 2012)).

Represented Merck Sharpe & Dohme Corporation in multi-district litigation in New Jersey federal court concerning allegations of a link between the company's osteoporosis medication, Fosamax, and atypical femur fractures.

Represented a large pharmaceutical company in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company's marketing and promotion of its prescription pain medication.

Represented HealthSouth Corporation in a case alleging fraudulent transfer and seeking to enforce a multimillion-dollar consent judgment obtained against a former HealthSouth subsidiary.

Served as trial counsel and obtained a defense verdict for Nissan North America, Inc. in a case alleging injuries as a result of a defective air bag system. (Simmons v. Nissan North America, Inc., No. CV206-103, S.D. Ga.).

Assisted clients in the evaluation, negotiation, and resolution of mass tort litigation.

Matters

Serves as core member of national coordinating and trial counsel team representing GlaxoSmithKline in nationwide product liability litigation concerning alleged associations between Paxil and birth defects, autism spectrum disorders, andsuicidality.  Ms. Redwine has experience conducting, coordinating, and managing discovery; drafting of dispositive and procedural motions; and trial preparation as well as working with expert witnesses that have spanned a broad array of scientific disciplines (teratology, obstetrics and maternal-fetal medicine, pediatric cardiology, developmental biology, genetics, and epidemiology).  Ms. Redwine currently manages the docket of cases, including conducting discovery and formulating litigation strategy, concerning allegations that maternal use of Paxil caused development of autism spectrum disorders in children exposed in utero.

Successfully represented GlaxoSmithKline in Rader v. GSK, a case involving allegations that Paxil caused a congenital heart defect (Tetralogy of Fallot). After two weeks of trial, the Philadelphia Court of Common Pleas granted a directed verdict for GSK for lack of evidence of learned intermediary proximate cause. Ms. Redwine also represented GlaxoSmithKline at two other  bellwether trials in the Philadelphia Court of Common Pleas involving allegations of birth defects caused by Paxil.

Successfully briefed and argued motion for summary judgment on various grounds, including statute of limitations, and assisted in obtaining dismissal on Daubert grounds for GlaxoSmithKline in a case alleging that maternal Paxil use caused congenital bicuspid aortic valve. (K.E. v. GlaxoSmithKline, 2017 WL 440242 (D. Conn. Feb. 1, 2017)).

See more
Icon close

Close

Matters

Serves as core member of national coordinating and trial counsel team representing GlaxoSmithKline in nationwide product liability litigation concerning alleged associations between Paxil and birth defects, autism spectrum disorders, andsuicidality.  Ms. Redwine has experience conducting, coordinating, and managing discovery; drafting of dispositive and procedural motions; and trial preparation as well as working with expert witnesses that have spanned a broad array of scientific disciplines (teratology, obstetrics and maternal-fetal medicine, pediatric cardiology, developmental biology, genetics, and epidemiology).  Ms. Redwine currently manages the docket of cases, including conducting discovery and formulating litigation strategy, concerning allegations that maternal use of Paxil caused development of autism spectrum disorders in children exposed in utero.

Successfully represented GlaxoSmithKline in Rader v. GSK, a case involving allegations that Paxil caused a congenital heart defect (Tetralogy of Fallot). After two weeks of trial, the Philadelphia Court of Common Pleas granted a directed verdict for GSK for lack of evidence of learned intermediary proximate cause. Ms. Redwine also represented GlaxoSmithKline at two other  bellwether trials in the Philadelphia Court of Common Pleas involving allegations of birth defects caused by Paxil.

Successfully briefed and argued motion for summary judgment on various grounds, including statute of limitations, and assisted in obtaining dismissal on Daubert grounds for GlaxoSmithKline in a case alleging that maternal Paxil use caused congenital bicuspid aortic valve. (K.E. v. GlaxoSmithKline, 2017 WL 440242 (D. Conn. Feb. 1, 2017)).

Obtained dismissal for GlaxoSmithKline of numerous claims, under Twombly/Iqbal, in a case alleging that Paxil caused adult valvular heart disease. Later, obtained summary judgment of remaining claims based on statute of limitations, and successfully briefed appeal to the United States Court of Appeals for the Fifth Circuit. (McLaughlin v. GSK, 2014 WL 669349 (W.D. La. Jan. 6, 2014) and 2014 WL 2200868 (W.D. La. May 27, 2014), aff'd 601 F. App'x 312 (5th Cir. Mar. 3, 2015)).

Obtained summary judgment for GlaxoSmithKline in a case alleging maternal Paxil use caused a congenital limb defect after the Court excluded plaintiffs' general and specific causation expert witnesses. (Frischhertz v. GSK, 2012 WL 6697124 (E.D. La. Dec. 21, 2012)).

Represented Merck Sharpe & Dohme Corporation in multi-district litigation in New Jersey federal court concerning allegations of a link between the company's osteoporosis medication, Fosamax, and atypical femur fractures.

Represented a large pharmaceutical company in an action filed by the Kentucky Attorney General seeking Medicaid-related costs and other damages allegedly caused by the company's marketing and promotion of its prescription pain medication.

Represented HealthSouth Corporation in a case alleging fraudulent transfer and seeking to enforce a multimillion-dollar consent judgment obtained against a former HealthSouth subsidiary.

Served as trial counsel and obtained a defense verdict for Nissan North America, Inc. in a case alleging injuries as a result of a defective air bag system. (Simmons v. Nissan North America, Inc., No. CV206-103, S.D. Ga.).

Assisted clients in the evaluation, negotiation, and resolution of mass tort litigation.

Credentials

J.D., University of Georgia School of Law, summa cum laude, Order of the Coif

B.S., University of Georgia, summa cum laude with highest honors

Georgia

Supreme Court of Georgia

U.S. Court of Appeals for the Eleventh Circuit

U.S. Court of Appeals for the Fifth Circuit

U.S. Court of Appeals for the Second Circuit

U.S. District Court for the Northern District of Georgia

U.S. District Court for the Western District of Tennessee

Law Clerk, Thomas W. Thrash, Jr., U.S. District Court for the Northern District of Georgia

Defense Research Institute

Graduate, International Association of Defense Counsel’s Trial Academy, 2015

International Association of Defense Counsel

Order of Barristers, University of Georgia School of Law, 2004

Order of the Coif, University of Georgia School of Law, 2004

State Bar of Georgia

Rising Star: Product Liability Litigation


Law360, 2017

Georgia Rising Star: Product Liability Litigation


Super Lawyers, 2011

Outstanding Mock Trial Advocate


University Of Georgia School Of Law, 2004

Regional Champion and Best Brief Award


National Moot Court Competition, 2003

Icon close

Close

Recognition

Rising Star: Product Liability Litigation


Law360, 2017

Georgia Rising Star: Product Liability Litigation


Super Lawyers, 2011

Outstanding Mock Trial Advocate


University Of Georgia School Of Law, 2004

Regional Champion and Best Brief Award


National Moot Court Competition, 2003